FOXP3 and non-small cell lung carcinoma: It was suggested that Foxp3+CD4+ T cells might in fact help to prevent or delay inflammation-mediated tumour development, as supported by the presence of remarkably higher levels of anti-inflammatory IL-10 from the serum samples of NSCLC patient [54].